recodetx.comHealthcareFounded: 2015Funding to Date: $323.57MM
Develops precision genetic medicines and therapies focused on Cystic Fibrosis, Primary Ciliary Dyskinesia and various cancers and central nervous system diseases.
For more details on financing and valuation for ReCode Therapeutics, register or login.
View Enterprise Value for ReCode Therapeutics.
To read this article and more news on ReCode Therapeutics, register or login.